PMID: 9160235May 1, 1997Paper

Recent advances in cardiopulmonary resuscitation

Journal of Cardiovascular Electrophysiology
K G Lurie, K H Lindner

Abstract

Mechanical and pharmacologic measures intended to increase blood flow to vital organs are the mainstay of therapy for patients in cardiac arrest. Several new cardiopulmonary resuscitation (CPR) techniques as well as novel devices and pharmacologic agents have been developed and tested since the first report of manual closed chested CPR over three decades ago. These recent mechanical and pharmacologic advances in the treatment of cardiac arrest are described. Some of these new techniques, devices, and drug therapies are presently undergoing clinical evaluation in patients in cardiac arrest. While many of these new methods and techniques have shown promise in small clinical trials in humans, none have yet to be found to be conclusively superior to manual closed chested CPR and treatment with standard pharmacologic agents.

References

Oct 1, 1992·Anesthesiology·K H LindnerM Georgieff
Sep 11, 1992·Annals of Emergency Medicine·J E ManningE A Norfleet
Oct 8, 1992·The New England Journal of Medicine·I G StiellG E Dickinson
Oct 8, 1992·The New England Journal of Medicine·J T Niemann
Jun 3, 1992·JAMA : the Journal of the American Medical Association·T J CohenM M Scheinman
Feb 15, 1991·The American Journal of Cardiology·K H LindnerA Grünert
Feb 1, 1990·Annals of Emergency Medicine·M S EisenbergT R Hearne
Nov 1, 1988·Pflügers Archiv : European journal of physiology·T IshikawaT Masaki
Mar 1, 1989·Annals of Emergency Medicine·D W OlsonC Aprahamian
May 15, 1989·Annals of Internal Medicine·M L WilliamsJ R Foster
Oct 1, 1988·Journal of the American College of Cardiology·I HelmyM M Scheinman
Jun 1, 1987·IEEE Transactions on Bio-medical Engineering·C K LinS M Yamashiro
Mar 1, 1985·The American Journal of Emergency Medicine·J R MateerJ C Darin
Jun 3, 1982·The New England Journal of Medicine·M S EisenbergL Bergner
Feb 1, 1980·Circulation·M T RudikoffM L Weisfeldt
Dec 1, 1994·The American Journal of Physiology·M R Eichinger, B R Walker
Jul 1, 1995·Pacing and Clinical Electrophysiology : PACE·K G Lurie, D Benditt
Aug 1, 1995·American Journal of Respiratory and Critical Care Medicine·W D PatrickD Roberts
Jul 1, 1993·Stroke; a Journal of Cerebral Circulation·Y SuzukiM Shibuya
Oct 1, 1994·Resuscitation·K G Lurie

❮ Previous
Next ❯

Citations

Jul 5, 2001·Current Opinion in Critical Care·K LurieC Soleil
Nov 23, 2006·Critical Care Medicine·Tom P Aufderheide, Keith G Lurie
Aug 26, 2015·Expert Review of Medical Devices·Guillaume DebatyKeith Lurie
Jun 5, 2007·The American Journal of Emergency Medicine·Meng-Hua ChenShu-Rong Mo
Apr 28, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Tom P AufderheideDavid G Benditt
Nov 13, 2015·Anesthesia and Analgesia·Keith G LurieMichael Sweeney
Aug 21, 2018·The Cochrane Database of Systematic Reviews·Peter L Wang, Steven C Brooks
Apr 8, 2006·Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine·P Morley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.